Have a personal or library account? Click to login
Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116 Cover

Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116

Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
By: Ana Testen,  Miha Plevnik,  Bogdan Štefane and  Irena Kralj Cigić  
Open Access
|Dec 2018
DOI: https://doi.org/10.2478/acph-2019-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 63 - 74
Accepted on: Sep 9, 2018
Published on: Dec 7, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
candesartan cilexetil (TCV-116),
diastereoisomers,
synthesis,
impurity,
HRMS
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Ana Testen, Miha Plevnik, Bogdan Štefane, Irena Kralj Cigić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 1 (March 2019)Next article